Data submission and quality in microarray-based MicroRNA profiling

Clinical Chemistry

Volumn 59, Issue 2, 2013, Pages 392-400

  Witwer, Kenneth W ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA;

ARTICLE; BIOMEDICINE; DATA BASE; DATA PROCESSING; EXPERIMENTAL DESIGN; GENE EXPRESSION; MICROARRAY ANALYSIS; PUBLICATION; QUALITY CONTROL; RNA SEQUENCE; SAMPLE; SAMPLE SIZE;

BIOLOGICAL MARKERS; GENE EXPRESSION PROFILING; HUMANS; INFORMATION DISSEMINATION; MICRORNAS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PERIODICALS AS TOPIC; RESEARCH DESIGN;

EID: 84873114749     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2012.193813     Document Type: Article

References (39)

1. Ioannidis JP. Why most published research findings are false. PLoS Med 2005;2:e124.
2. Begley CG, Ellis LM. Drug development: raise standards for preclinical cancer research. Nature 2012;483:531-3.
3. Prinz F, Schlange T, Asadullah K. Believe it or not: how much can we rely on published data on potential drug targets? Nat Rev Drug Discov 2011;10:712.
4. Wicherts JM, Bakker M, Molenaar D. Willingness to share research data is related to the strength of the evidence and the quality of reporting of statistical results. PloS One 2011;6:e26828.
5. Brazma A, Hingamp P, Quackenbush J, Sherlock G, Spellman P, Stoeckert C, et al. Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nat Genet 2001;29:365-71.
6. Brazma A. Minimum Information About a Microarray Experiment (MIAME)-successes, failures, challenges. ScientificWorldJournal 2009;9: 420-3.
7. Edgar R, Domrachev M, Lash AE. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res 2002;30:207-10.
8. Ikeo K, Ishi-i J, Tamura T, Gojobori T, Tateno Y. CIBEX: center for information biology gene expression database. C R Biol 2003;326:1079-82.
9. Brazma A, Parkinson H, Sarkans U, Shojatalab M, Vilo J, Abeygunawardena N, et al. ArrayExpress-a public repository for microarray gene expression data at the EBI. Nucleic Acids Res 2003;31:68 -71.
10. Ioannidis JP, Allison DB, Ball CA, Coulibaly I, Cui X, Culhane AC, et al. Repeatability of published microarray gene expression analyses. Nat Genet 2009;41:149 -55.
11. Fabbri M. miRNAs as molecular biomarkers of cancer. Expert Rev Mol Diagn 2010;10:435-44.
12. Krutovskikh VA, Herceg Z. Oncogenic microRNAs (OncomiRs) as a new class of cancer biomarkers. Bioessays 2010;32:894 -904.
13. Allantaz F, Cheng DT, Bergauer T, Ravindran P, Rossier MF, Ebeling M, et al. Expression profiling of human immune cell subsets identifies miRNAmRNA regulatory relationships correlated with cell type specific expression. PLoS One 2012;7: e29979.
14. Chen J, Zhang X, Lentz C, Abi-Daoud M, Pare GC, Yang X, et al. miR-193b regulates Mcl-1 in melanoma. Am J Pathol 2011;179:2162-8.
15. Mellios N, Sugihara H, Castro J, Banerjee A, Le C, Kumar A, et al. miR-132, an experiencedependent microRNA, is essential for visual cortex plasticity. Nat Neurosci 2011;14:1240 -2.
16. Bignami F, Pilotti E, Bertoncelli L, Ronzi P, Gulli M, Marmiroli N, et al. Stable changes in CD4+ T-lymphocyte microRNA expression following exposure to HIV-1. Blood 2012;119:6259-67.
17. Huang L, Lin JX, Yu YH, Zhang MY, Wang HY, Zheng M. Downregulation of six microRNAs is associated with advanced stage, lymph node metastasis and poor prognosis in small cell carcinoma of the cervix. PLoS One 2012;7: e33762.
18. Gupta A, Nagilla P, Le HS, Bunney C, Zych C, Thalamuthu A, et al. Comparative expression profile of miRNA and mRNA in primary peripheral blood mononuclear cells infected with human immunodeficiency virus (HIV-1). PLoS One 2011; 6:e22730.
19. Rahman S, Quann K, Pandya D, Singh S, Khan ZK, Jain P. HTLV-1 tax mediated downregulation of miRNAs associated with chromatin remodeling factors in T cells with stably integrated viral promoter. PLoS One 2012;7:e34490.
20. Mohan KV, Devadas K, Sainath Rao S, Hewlett I, Atreya C. Identification of XMRV infectionassociated microRNAs in four cell types in culture. PLoS One 2012;7:e32853.
21. Sisk JM, Clements JE, Witwer KW. miRNA profiles of monocyte-lineage cells are consistent with complicated roles in HIV-1 restriction. Viruses 2012;4:1844-64.
22. Witwer KW, Clements JE. Evidence for miRNA expression differences of HIV-1-positive, treatment-naive patients and elite suppressors: a re-analysis. Blood 2012;119:6395-6.
23. Witwer KW, Sarbanes SL, Liu J, Clements JE. A plasma microRNA signature of acute lentiviral infection: biomarkers of CNS disease. AIDS 2011; 204:1104 -14.
24. Witwer KW, Watson AK, Blankson JN, Clements JE. Relationships of PBMC microRNA expression, plasma viral load, and CD4+ T-cell count in HIV-1-infected elite suppressors and viremic patients. Retrovirology 2012;9:5.
25. Palacin M, Reguero JR, Martin M, Diaz Molina B, Moris C, Alvarez V, Coto E. Profile of microRNAs differentially produced in hearts from patients with hypertrophic cardiomyopathy and sarcomeric mutations. Clin Chem 2011;57:1614-6.
26. Lang MF, Yang S, Zhao C, Sun G, Murai K, Wu X, et al. Genome-wide profiling identified a set of miRNAs that are differentially expressed in glioblastoma stem cells and normal neural stem cells. PLoS One 2012;7:e36248.
27. Li Z, Huang H, Li Y, Jiang X, Chen P, Arnovitz S, et al. Up-regulation of a HOXA-PBX3 homeoboxgene signature following down-regulation of miR-181 is associated with adverse prognosis in patients with cytogenetically abnormal AML. Blood 2012;119:2314 -24.
28. Saba R, Gushue S, Huzarewich RL, Manguiat K, Medina S, Robertson C, Booth SA. MicroRNA 146a (miR-146a) is over-expressed during prion disease and modulates the innate immune response and the microglial activation state. PLoS One 2012;7:e30832.
29. Yang MH, Lin BR, Chang CH, Chen ST, Lin SK, Kuo MY, et al. Connective tissue growth factor modulates oral squamous cell carcinoma invasion by activating a miR-504/FOXP1 signalling. Oncogene 2012;31:2401-11.
30. Retraction: Comparative expression profile of miRNA and mRNA in primary peripheral blood mononuclear cells infected with human immunodeficiency virus (HIV-1). PLoS One 2012;7(8).
31. Moore A. Have we produced enough results yet, Sir? BioEssays 2012;34:163.
32. Liu S, Guo W, Shi J, Li N, Yu X, Xue J, et al. MicroRNA-135a contributes to the development of portal vein tumor thrombus by promoting metastasis in hepatocellular carcinoma. J Hepatol 2012;56:389 -96.
33. Tilghman SL, Bratton MR, Segar HC, Martin EC, Rhodes LV, Li M, et al. Endocrine disruptor regulation of microRNA expression in breast carcinoma cells. PLoS One 2012;7:e32754.
34. Pasha Z, Haider H, Ashraf M. Efficient non-viral reprogramming of myoblasts to stemness with a single small molecule to generate cardiac progenitor cells. PLoS One 2011;6:e23667.
35. Tano N, Kim HW, Ashraf M. microRNA-150 regulates mobilization and migration of bone marrow-derived mononuclear cells by targeting Cxcr4. PLoS One 2011;6:e23114.
36. Xu J, Kang Y, Liao WM, Yu L. MiR-194 regulates chondrogenic differentiation of human adiposederived stem cells by targeting Sox5. PLoS One 2012;7:e31861.
37. Raychaudhuri S. MicroRNAs overexpressed in growth-restricted rat skeletal muscles regulate the glucose transport in cell culture targeting central TGF-beta factor SMAD4. PLoS One 2012; 7:e34596.
38. Biyashev D, Veliceasa D, Topczewski J, Topczewska JM, Mizgirev I, Vinokour E, et al. miR-27b controls venous specification and tip cell fate. Blood 2012;119:2679-87.
39. Nair VS, Maeda LS, Ioannidis JP. Clinical outcome prediction by microRNAs in human cancer: a systematic review. J Natl Cancer Inst 2012;104:528-40.